In the latest session, Summit Therapeutics Inc (NASDAQ: SMMT) closed at $3.37 down -5.07% from its previous closing price of $3.55. In other words, the price has decreased by -$0.1800 from its previous closing price. On the day, 2813594 shares were traded. SMMT stock price reached its highest trading level at $3.5400 during the session, while it also had its lowest trading level at $3.2600.
Ratios:
For a deeper understanding of Summit Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.30 and its Current Ratio is at 9.30. In the meantime, Its Debt-to-Equity ratio is 1.37 whereas as Long-Term Debt/Eq ratio is at 1.33.
Needham reiterated its Buy rating for the stock on April 12, 2018, while the target price for the stock was revised from $30 to $27.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 13 ’23 when Dhingra Ankur bought 20,400 shares for $2.17 per share. The transaction valued at 44,254 led to the insider holds 254,958 shares of the business.
Zanganeh Mahkam bought 5,000 shares of SMMT for $10,350 on Dec 12 ’23. The Chief Executive Officer now owns 494,814 shares after completing the transaction at $2.07 per share. On Oct 13 ’23, another insider, Soni Manmeet Singh, who serves as the Chief Operating Officer of the company, bought 2,976,190 shares for $1.68 each. As a result, the insider paid 4,999,999 and bolstered with 2,976,190 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SMMT now has a Market Capitalization of 2.36B and an Enterprise Value of 2.28B. Its current Enterprise Value per Revenue stands at 6.43k whereas that against EBITDA is -3.83.
Stock Price History:
Over the past 52 weeks, SMMT has reached a high of $5.22, while it has fallen to a 52-week low of $1.30. The 50-Day Moving Average of the stock is 4.1588, while the 200-Day Moving Average is calculated to be 2.5789.
Shares Statistics:
For the past three months, SMMT has traded an average of 2.23M shares per day and 3.3M over the past ten days. A total of 701.66M shares are outstanding, with a floating share count of 83.26M. Insiders hold about 88.13% of the company’s shares, while institutions hold 4.64% stake in the company. Shares short for SMMT as of Feb 29, 2024 were 15.95M with a Short Ratio of 7.16, compared to 11.3M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 2.27% and a Short% of Float of 19.16%.
Earnings Estimates
There are 0 different market analysts currently analyzing its stock. On average, analysts expect EPS of $0 for the current quarter, with a high estimate of $0 and a low estimate of $0, while EPS last year was -$1.24. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0. EPS for the following year is $0, with 0 analysts recommending between $0 and $0.
Revenue Estimates
A total of 1 analysts have provided revenue estimates for SMMT’s current fiscal year. The highest revenue estimate was $1.56M, while the lowest revenue estimate was $1.56M, resulting in an average revenue estimate of $1.56M. In the same quarter a year ago, actual revenue was $20.17M, down -92.30% from the average estimate.
